电针预处理通过心肌缺血损伤 棕色脂肪组织和 BMP3b/Smad1/5 通路小鼠 by Danying Qian (21730250)

Subjects: “…electroacupuncture significantly decreased…”

Box plots showing the taxa that were significantly different between thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

The presence of the gRNA targeting <i>OPG147</i> has no effect on transcription of viral entry and early genes. by Xue-Mei Yi (18851202)

Mutation of vOPG147 F55, T116 and T117 does not affect replication and production of VACV. by Xue-Mei Yi (18851202)

vOPG147-deficiency promotes innate immune response to VACV. by Xue-Mei Yi (18851202)

OPG147 is associated with MITA. by Xue-Mei Yi (18851202)

OPG147 inhibits ISGylation, dimerization and oligomerization of MITA. by Xue-Mei Yi (18851202)

OPG147-deficiency promotes innate immune response to MPXV. by Xue-Mei Yi (18851202)

OPG147 contributes to VACV evasion of host defense and is a virulence factor <i>in vivo.</i> by Xue-Mei Yi (18851202)

Sox2 is upstream of <i>Atoh1</i> and <i>Huwe1</i> in embryonic development and <i>Huwe1</i> knockdown results in hair cell generation from dividing supporting cells. by Yen-Fu Cheng (5819855)

Necroptosis related gene set derived from GeneCards database. by Qingxia Lin (6320222)

Conformational projection in principal component analysis. by Mohammed Alrouji (14582398)

Subjects:

The top 10 relevant PASS predictions of the screened molecules. by Mohammed Alrouji (14582398)

Subjects:

Fig 2 - by Mohammed Alrouji (14582398)

Subjects:

Fig 6 - by Mohammed Alrouji (14582398)

Subjects:

Fig 8 - by Mohammed Alrouji (14582398)

Subjects:

Dynamics of hydrogen bonds. by Mohammed Alrouji (14582398)

Subjects:

The top 10 hits based on their docking scores towards CatB. by Mohammed Alrouji (14582398)

Subjects:

CatB in complex with the screened molecules. by Mohammed Alrouji (14582398)

Subjects:

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. by Ananya Datta (19932144)